| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Revenue | $2.09B | +17.4% |
| Cost of Revenue | $1.28B | -3.0% |
| R&D Expense | $55.9M | +13.6% |
| SG&A Expense | $521.2M | +1.5% |
| Operating Income | $283.8M | +648.8% |
| Interest Expense | $22.7M | +124.8% |
| Pre-tax Income | $267.0M | -1.6% |
| Income Tax | $63.2M | -36.7% |
| Net Income | $255.9M |
| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $329.6M | -22.8% |
| Accounts Receivable | $306.4M | +12.9% |
| Inventory | $353.1M | +20.0% |
| Current Assets | $1.09B | -3.5% |
| Total Assets | $2.33B | +3.0% |
| Current Liabilities | $467.1M | -44.8% |
| Long-term Debt | $248.5M | — |
| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Capital Expenditures | $42.7M | +15.1% |
| Financing Cash Flow | -$423.2M | -499.2% |
| -36.2% |
| EPS (Basic) | $4.51 | -36.6% |
| EPS (Diluted) | $4.45 | -36.5% |
| Stockholders' Equity |
| $1.36B |
| +19.2% |